PURPOSE: To determine systemic factors associated with central serous chori
oretinopathy.
METHODS: In a retrospective study, 230 consecutive patients with central se
rous chorioretinopathy examined in a referral setting were compared with a
historical gender-matched and age-matched control group of 230 patients wit
h ocular findings who were examined in the same referral setting.
RESULTS: The median age of the patients was 49.8 years, and of the control
subjects, 50.0 years. The male-female ratio for both groups was 2.7:1. Pati
ents with central serous chorioretinopathy were more likely to use psychoph
armacologic medications (odds ratio = 2.6; 95% confidence interval = 1.30 t
o 5.19; P = .0049) and corticosteroids (odds ratio = 3.17; 95% confidence i
nterval = 1.30 to 7.70; P = .0067) and were more likely to have hypertensio
n (odds ratio = 2.25; 95% confidence interval = 1.39 to 3.63; P = .0008) th
an were the control subjects.
CONCLUSIONS: This study identified psychopharmacologic medication use, cort
icosteroid use, and hyper tension as factors associated with central serous
chorioretinopathy. These findings reinforce the concept that stress and ad
aptations to stress play a role in this disorder, The findings of possible
associations between central serous chorioretinopathy and both hypertension
and corticosteroid usage suggest that these modifiable factors may influen
ce morbidity of central serous chorioretinopathy. (Am J Ophthalmol 1999;128
:63-68. (C) 1999 by Elsevier Science Inc. All rights reserved.)